BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Volpedo G, Costa L, Ryan N, Halsey G, Satoskar A, Oghumu S. Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases. J Venom Anim Toxins Incl Trop Dis 2019;25:e144118. [PMID: 31130996 DOI: 10.1590/1678-9199-JVATITD-1441-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Sánchez A, Mejía SP, Orozco J. Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections. Molecules 2020;25:E3760. [PMID: 32824757 DOI: 10.3390/molecules25163760] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
2 Aminu N, Bello I, Umar NM, Tanko N, Aminu A, Audu MM. The influence of nanoparticulate drug delivery systems in drug therapy. Journal of Drug Delivery Science and Technology 2020;60:101961. [DOI: 10.1016/j.jddst.2020.101961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Pandian SRK, Panneerselvam T, Pavadai P, Govindaraj S, Ravishankar V, Palanisamy P, Sampath M, Sankaranarayanan M, Kunjiappan S. Nano Based Approach for the Treatment of Neglected Tropical Diseases. Front Nanotechnol 2021;3:665274. [DOI: 10.3389/fnano.2021.665274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Muraca G, Berti IR, Sbaraglini ML, Fávaro WJ, Durán N, Castro GR, Talevi A. Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers. Front Chem 2020;8:601151. [PMID: 33324615 DOI: 10.3389/fchem.2020.601151] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Matha K, Calvignac B, Gangneux JP, Benoit JP. The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking. Expert Opin Drug Deliv 2021;18:471-87. [PMID: 33217254 DOI: 10.1080/17425247.2021.1853701] [Reference Citation Analysis]
6 Pereira IAG, Mendonça DVC, Tavares GSV, Lage DP, Ramos FF, Oliveira-da-Silva JA, Antinarelli LMR, Machado AS, Carvalho LM, Carvalho AMRS, Salustiano IV, Reis TAR, Bandeira RS, Silva AM, Martins VT, Chávez-Fumagalli MA, Humbert MV, Roatt BM, Duarte MC, Menezes-Souza D, Coimbra ES, Leite JPV, Coelho EAF, Gonçalves DU. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis. Parasite Immunol 2020;42:e12784. [PMID: 32772379 DOI: 10.1111/pim.12784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 de Souza C, Carvalho JA, Abreu AS, de Paiva LP, Ambrósio JAR, Junior MB, de Oliveira MA, Mittmann J, Simioni AR. Polyelectrolytic gelatin nanoparticles as a drug delivery system for the promastigote form of Leishmania amazonensis treatment. J Biomater Sci Polym Ed 2021;32:1-21. [PMID: 32847485 DOI: 10.1080/09205063.2020.1815495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Araujo VHS, Duarte JL, Carvalho GC, Silvestre ALP, Fonseca-Santos B, Marena GD, Ribeiro TC, Dos Santos Ramos MA, Bauab TM, Chorilli M. Nanosystems against candidiasis: a review of studies performed over the last two decades. Crit Rev Microbiol 2020;46:508-47. [PMID: 32795108 DOI: 10.1080/1040841X.2020.1803208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
9 Şenel S, Yüksel S. Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases. Drug Deliv Transl Res 2020;10:1644-74. [PMID: 32588282 DOI: 10.1007/s13346-020-00806-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Rani R, Kumar S, Dilbaghi N, Kumar R. Nanotechnology enabled the enhancement of antitrypanosomal activity of piperine against Trypanosoma evansi. Experimental Parasitology 2020;219:108018. [DOI: 10.1016/j.exppara.2020.108018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kunjiappan S, Pavadai P, Vellaichamy S, Ram Kumar Pandian S, Ravishankar V, Palanisamy P, Govindaraj S, Srinivasan G, Premanand A, Sankaranarayanan M, Theivendren P. Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review. Drug Dev Res 2021;82:309-40. [DOI: 10.1002/ddr.21758] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
12 Volpedo G, Huston RH, Holcomb EA, Pacheco-Fernandez T, Gannavaram S, Bhattacharya P, Nakhasi HL, Satoskar AR. From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection. Expert Rev Vaccines 2021;:1-16. [PMID: 34511000 DOI: 10.1080/14760584.2021.1969231] [Reference Citation Analysis]
13 Ibrahim EI, Abou-El-Naga IF, El-Temsahy MM, Elsawy ESA, Makled S, Mogahed NMFH. A single oral dose of celecoxib-loaded solid lipid nanoparticles for treatment of different developmental stages of experimental schistosomiasis mansoni. Acta Trop 2022;229:106342. [PMID: 35157841 DOI: 10.1016/j.actatropica.2022.106342] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chung I, Subramanian U, Thirupathi P, Venkidasamy B, Samynathan R, Gangadhar BH, Rajakumar G, Thiruvengadam M. Resveratrol Nanoparticles: A Promising Therapeutic Advancement over Native Resveratrol. Processes 2020;8:458. [DOI: 10.3390/pr8040458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kammona O, Tsanaktsidou E. Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis. Int J Pharm 2021;605:120761. [PMID: 34081999 DOI: 10.1016/j.ijpharm.2021.120761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Norman FF, Comeche B, Chamorro S, Pérez-Molina JA, López-Vélez R. Update on the major imported protozoan infections in travelers and migrants. Future Microbiol 2020;15:213-25. [PMID: 32065535 DOI: 10.2217/fmb-2019-0212] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
17 de Araújo JTC, Duarte JL, Di Filippo LD, Araújo VHS, Carvalho GC, Chorilli M. Nanosystem functionalization strategies for prostate cancer treatment: a review. J Drug Target 2021;29:808-21. [PMID: 33645369 DOI: 10.1080/1061186X.2021.1892121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Alven S, Aderibigbe BA. Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria. Pharmaceutics 2020;12:E748. [PMID: 32784933 DOI: 10.3390/pharmaceutics12080748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]